Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.
about
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisBudesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisCurrent approaches to the management of new-onset ulcerative colitis.Mesalazine in inflammatory bowel disease: a trendy topic once again?Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.Pros and cons of medical management of ulcerative colitis.Current treatment of ulcerative colitisEmerging drugs for the treatment of ulcerative colitisUpdate on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine.One-year investigator-blind randomized multicenter trial comparing Asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitisUlcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.Therapeutic strategies for the management of ulcerative colitis.Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial.Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine.Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.Second Korean guidelines for the management of ulcerative colitis.Adherence in ulcerative colitis: an overview.Advances in the management of inflammatory bowel disease.Efficacy and safety of drugs for ulcerative colitis.MMX® Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis.Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease.Update on the management of ulcerative colitis.Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.Optimization of conventional therapy in patients with IBD.Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis.Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis.Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitis.Indian Society of Gastroenterology consensus on ulcerative colitis.The role of Budesonide-MMX in active ulcerative colitis.Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.Current and emerging maintenance therapies for ulcerative colitis.Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.MMX® technology and its applications in gastrointestinal diseases.Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease
P2860
Q24185774-513DA9E9-323A-474F-9D71-827C3115FE75Q24198786-AD177048-2FE2-4933-8DBA-075A5421578FQ26779042-32AA087D-9C78-481E-8575-080533C97FA7Q33633288-965CD2A3-D1DF-4948-96F7-FE8E2353AE54Q33779797-7BD6D75D-9935-4712-A51E-1C0D1EFBB0B8Q34273329-48FEEF34-425A-4BBB-BDF2-2C797F917A02Q35100726-14E584FE-5909-4A13-99B8-869C31095D6CQ35171533-BC2E669D-DF69-4B8B-9CAF-EA0288313340Q36039436-9A42D3BF-AEB7-451D-8738-C5878FC1C803Q36144377-9EBC99C8-DBCE-4B23-B689-0AD15F7F7A5AQ37101734-42123823-B27F-419E-A695-9DCBA6679C85Q37129225-1086F15F-5A5B-43F3-9C8F-04BDC50921E8Q37318035-6A309E9C-1D67-4383-B251-8476CC74CDA4Q37405555-281D3EFA-326A-4767-A0BA-02BB83C72BC2Q37423752-4BE3E69D-E58F-406C-BA84-6E3DEA525AF8Q37600339-BB0A48B7-8812-4760-A049-3743877CBF95Q37662503-2F699B10-BCC3-4A04-959F-4653DD7AA5D9Q37669367-944B78BA-5E30-4302-9CB4-8C1F62D45801Q37670984-FAE86014-CAFE-4B5D-A53C-5957F081A989Q37727232-2FD3CE6E-4683-4F0A-B999-9214FEF3ED1BQ37833064-84D6E27F-37A3-4852-A4BF-5C1E33A2CB29Q37892884-3908CDF1-5186-4683-88D5-D147DC712BBFQ37905652-0B25596B-4D06-410C-B279-E5868D64DDC8Q37926915-4ED3D1B2-8DB4-45C1-A480-1B9BDFA382D2Q37942292-92EA3A54-BE78-4341-A674-FC6F4CF2D74FQ37995669-87D0BBAE-C115-4DAF-AB3B-57A9E3355869Q38014364-673EB64B-FD8B-47EA-A44D-3308D4BFAF09Q38017299-D4DA4F2B-368A-4B74-8F51-9106394A15B5Q38042702-B32FF2CF-6A58-4A37-AC6C-1ED2CA10C620Q38055371-B668D01A-CDE0-4DB9-8D80-EA12D8A40537Q38185703-59DBECBF-6DD9-47D4-93D1-DB5A284F2837Q38196945-1C541ABD-8DFC-4A6C-B0D0-042977F5493FQ38197719-59B45B66-CEBD-40B2-89F3-4FD949E5E86EQ38383015-8A37BC9A-DB64-4B94-BE23-72F38821764EQ38625992-5F677822-5D11-4C21-AB6E-E96582C39FEFQ38841927-24D2D814-08A1-4B14-A4E7-E7DEF50BD6EBQ38996677-A3F9BF34-C0A1-464F-B012-DA8E17874864Q39098635-DDD79632-7A39-4738-8147-628AA538429BQ40095211-4EADA7BA-35E1-4CCB-9EC2-34D8731D5F72Q41891210-1B1749A3-4831-4576-B1B2-F1DD3E928837
P2860
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Randomised trial of once- or t ...... mission in ulcerative colitis.
@en
type
label
Randomised trial of once- or t ...... mission in ulcerative colitis.
@en
prefLabel
Randomised trial of once- or t ...... mission in ulcerative colitis.
@en
P2093
P2860
P356
P1433
P1476
Randomised trial of once- or t ...... mission in ulcerative colitis.
@en
P2093
P2860
P304
P356
10.1136/GUT.2007.138248
P407
P577
2008-02-13T00:00:00Z